Kidney atrophy vs hypertrophy in diabetes: which cells are involved?

References

• Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int. 1999;56:1627–1637.
   PubMed Web of Science ®Google Scholar
• Jones SC, Saunders HC, Qi W. Pollock CA: intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetologia. 1999;42:1113–1119.
   PubMed Web of Science ®Google Scholar
• Jones SC, Saunders HJ. Pollock CA: high glucose increases cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabet Med. 1999;16:932–938.
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN, Snipes ER, Watanabe M, et al. Haverty TP: high glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol Renal Fluid Electrolyte Physiol. 1990;259:F704–F714.
   PubMedGoogle Scholar
• Tsao T, Fawcett J, Fervenza FC, et al. Rabkin R: expression of insulin-like growth factor-I and transforming growth factor-beta in hypokalemic nephropathy in the rat. Kidney Int. 2001;59:96–105.
   PubMed Web of Science ®Google Scholar
• Habib SL. Alterations in tubular epithelial cells in diabetic nephropathy. J Nephrol. 2013;26:865–869.
   PubMed Web of Science ®Google Scholar
• Marchant V, Droguett A, Valderrama G, et al. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy. Am J Physiol Renal Physiol. 2015;309:F559–68.
   PubMed Web of Science ®Google Scholar
• Habib SL, Mohan S, Liang S, et al. Novel mechanism of transcriptional regulation of cell matrix protein through CREB. Cell Cycle. 2015;14:2598–2608.
   PubMed Web of Science ®Google Scholar
• Robertson H, Ali S, McDonnell BJ, et al. Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol. 2004;15:390–397.
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev. 2008;4:39–45.
   PubMedGoogle Scholar
• Djamali A. Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts. Am J Physiol Renal Physiol. 2007;293:F445–55.
   PubMed Web of Science ®Google Scholar
• Liang S, Salas T, Gencaslan E, et al. Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients. Oncotarget. 2014;5:6936–6946.
   PubMedGoogle Scholar
• Habib SL. Tuberin in renal cell hypertrophy. Cell Cycle. 2014;13:869–870.
   PubMed Web of Science ®Google Scholar
• Habib SL, Yadav M, Tizani S, et al. Tuberin inhibits production of the matrix protein fibronectin in diabetes. J Am Soc Nephrol. 2012;23:1652–1662.
   PubMed Web of Science ®Google Scholar
• Potter CJ, Huang H, Xu T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell. 2001;105:357–368.
   PubMed Web of Science ®Google Scholar
• Inoki K, Li Y, Zhu T, et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling. Nat Cell Biol. 2002;4:648–657.
   PubMed Web of Science ®Google Scholar
• Lieberthal W, Levine JS. The role of the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc Nephrol. 2009;12:2493–2502.
   Google Scholar
• Yang X, Xu T. Molecular mechanism of size control in development and human diseases. Cell Res. 2011;21:715–729.
   PubMed Web of Science ®Google Scholar
• Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl. 2000;77:S59–6.
   PubMedGoogle Scholar
• Alsaad KO, Herzenberg AM. Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. J Clin Pathol. 2007;60:18–26.
   PubMed Web of Science ®Google Scholar
• Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 1999;56:393–405.
   PubMed Web of Science ®Google Scholar
• Gruden G, Perin PC, Camussi G. Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. Curr Diabetes Rev. 2005;1:27–40.
   PubMedGoogle Scholar
• Velagapudi C, Bhandari BS, Abboud-Werner S, et al. The tuberin/mTOR pathway promotes apoptosis of tubular epithelial cells in diabetes. J Am Soc Nephrol. 2011;22:262–273.
   PubMed Web of Science ®Google Scholar
• Vallon V, Thomson SC. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol. 2012;74:351–357.
   PubMed Web of Science ®Google Scholar
• Gnudi L. Molecular mechanisms of proteinuria in diabetes. Biochem Soc Trans. 2008;36:946–949.
   PubMed Web of Science ®Google Scholar
• Cui R, Chen X, Peng L, et al. Multiple mechanisms in renal artery stenosis-induced renal interstitial fibrosis. Nephron Exp Nephrol. 2014;128:57–66.
   PubMedGoogle Scholar
• Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121:4210–4221.
   PubMed Web of Science ®Google Scholar
• Meyrier A, Hill GS, Simon P. Ischemic renal diseases: new insights into old entities. Kidney Int. 1998;54:2–13.
   PubMed Web of Science ®Google Scholar
• Dillon MJ, Goonasekera CD. Reflux nephropathy. J Am Soc Nephrol. 1998;9:2377–2383.
   PubMed Web of Science ®Google Scholar
• Biaggioni I, Garcia F, Inagami T, et al. Hyporeninemic normoaldosteronism in severe autonomic failure. J Clin Endocrinol Metab. 1993;76:580–586.
   PubMed Web of Science ®Google Scholar
• Klahr S. Mechanisms of progression of chronic renal damage. J Nephrol. 1999;(Suppl 2):S53–62.
   PubMedGoogle Scholar
• Lucarelli G, Mancini V, Galleggiante V, et al. Emerging urinary markers of renal injury in obstructive nephropathy. Biomed Res Int. 2014;2014:1–7.
   Web of Science ®Google Scholar
• Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discovery. 2015;14:58–74.
   PubMed Web of Science ®Google Scholar